Braun Bostich & Associates Inc. Novartis Ag Transaction History

Braun Bostich & Associates Inc.

$140 Million
Q3 2024

A detailed history of Braun Bostich & Associates Inc. transactions in Novartis Ag stock. As of the latest transaction made, Braun Bostich & Associates Inc. holds 2,354 shares of NVS stock, worth $228,526. This represents 0.19% of its overall portfolio holdings.

Number of Shares

2,354

Previous 2,206 6.71%

Holding current value

$228,526

Previous $234,000 15.38%

% of portfolio

0.19%

Previous 0.18%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$106.13 - $120.89 $15,707 - $17,891	148 Added 6.71%	2,354 $270,000
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $204,209 - $236,858	2,206 New	2,206 $234,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $27,636 - $33,428	-354 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$82.14 - $91.0 $39,016 - $43,225	-475 Reduced 57.3%	354 $31,000
Q4 2019 Jan 29, 2020	BUY	$84.35 - $95.37 $69,926 - $79,061	829 New	829 $79,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $119,157 - $131,304	-1,393 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $81,582 - $100,409	-1,082 Reduced 43.72%	1,393 $127,000
Q1 2019 May 09, 2019	SELL	$75.32 - $86.15 $287,044 - $328,317	-3,811 Reduced 60.63%	2,475 $238,000
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $10,386 - $11,564	-141 Reduced 2.19%	6,286 $539,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $19,412 - $22,454	290 Added 4.73%	6,427 $554,000
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $11,618 - $13,131	179 Added 3.0%	6,137 $464,000
Q1 2018 May 16, 2018	BUY	$70.39 - $84.15 $96,715 - $115,622	1,374 Added 29.97%	5,958 $0
Q4 2017 May 21, 2018	BUY	$72.33 - $77.64 $331,560 - $355,901	4,584	4,584 $385,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.

Account

Braun Bostich & Associates Inc. Novartis Ag Transaction History